Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
This study has been completed.
Study NCT00005893 Information provided by Office of Rare Diseases (ORD)
First Received: June 2, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neutropenia
Sickle Cell Anemia
Thalassemia Major
Red-Cell Aplasia, Pure
Additional conditions recognized in this trial
Anemia
Anemia, Sickle Cell
Beta-Thalassemia
Hematologic Diseases
Thalassemia
More general conditions related to this trial
Agranulocytosis
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hemoglobinopathies
Leukocyte Disorders
Leukopenia
Interventions listed in this trial
anti-thymocyte globulin
busulfan
cyclophosphamide
Bone marrow transplantation
Additional drug interventions recognized in this trial
Antilymphocyte Serum
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Fairview University Medical Center
Back to top of Main Content
